The Partnership for Safe Medicines 2011 Interchange

Partnership for Safe Medicines 2011 Interchange Conference Archive Opening remarks from Scott LaGanga, PSM Executive Director [ Read blog ] [ Watch video ] Video statement from Sen. Bennett (CO) [ Watch video | Read blog ] Comments from Rep. Jim Matheson (UT) [ Read blog ] [ Watch video ] Protecting our medicines: moderated…

[...]

Interchange 2011 Wrap Up

From the Maryland Attorney General, to the International Association of Patient Organizations, the second annual Partnership for Safe Medicines Interchange 2011 provided local and international perspectives on the issues involving counterfeit medicine. The Partnership for Safe Medicines 2011 Interchange on October 27, began with dynamic remarks from Colorado Senator Michael Bennet and Congressman Jim Matheson…

[...]

Keynote Address; Deputy Director Kumar Kibble

Deputy Director Kumar Kibble of the U.s. Immigration and Customs Enforcement (ICE), Department of Homeland Security delivered the keynote address.   Kibble started his remarks by reminding us that he is personally inspired Dr. Francses Kelsey of the FDA who blocked the use of thalidomide in the US for pregnant women in 1960, while over 10,000 children in other…

[...]

Under Secretary of State Hormats at Interchange: Global Collaboration Key to Curb the Spread of Counterfeit Medicines

Collaboration within the U.S. government, collaboration between governments themselves, and collaboration with the private sector and, all stakeholder groups is essential to the fight against counterfeit and substandard medicines, said U.S. Under Secretary of State Robert D. Hormats during a speech today at the annual Interchange hosted today by the Partnership for Safe Medicines (PSM).

[...]

Panel 3: Jeremiah Mwangi, International Alliance of Patients’ Organizations

At the third panel, "Safe Medicines: The Role of Patients & Healthcare Professionals," Jeremiah Mwangi, Policy & External Affairs Director, International Alliance of Patients' Organizations, spoke on the role of patients.   Mwangi said that counterfeit drugs are a matter of patient safety, eroding trust in healthcare systems, and creating a public health risk. IAPO has…

[...]

Panel 3: Connie Jung, Office of Drug Security, Integrity and Recalls

The second panelist, Connie Jung from the Office of Drug Security, Integrity and Recall from the U.S. Food and Drug Administration spoke about how to help patients protect themselves from counterfeit drugs. She said that patients first of all need to be aware of the risk of receiving counterfeit medications and potential problems associated with…

[...]

Panel 3: Xuanhao Chan, International Pharmaceutical Federation

Bejon Misra, Founder of Partnership for Safe Medicines India, moderated the third panel, "The Role of Patients & Healthcare Professionals."   Misra began the session by showing a video that highlights the work of PSM India.  Misra began by distributing tokens of appreciation from the Board of PSM India to the Board of Partnership for…

[...]

Under Secretary Robert Hormats talks about international outreach to fight fake drugs

Bob Hormats, Under Secretary of State for Economic, Energy and Agricultural Affairs was the luncheon speaker at the Partnership for Safe Medicines 2011 Interchange. Below is a transcript of Under Secretary Hormats remarks. I’m delighted that you asked me to speak today.  The work that the Partnership for Safe Medicines is important. Making sure that…

[...]

Panel 2: Maryland Attorney General, Douglas F. Gansler

Maryland Attorney General, Douglas F. Gansler, spoke on Panel 2.   Said Gansler, "We all have a blind trust in the drugs we take, the doctor says we'll get better when we take it, and we trust that medication is what it purports to be. "But counterfeit drugs make it not the case. " Said…

[...]

Panel 2: Libby Baney, Alliance for Safe Online Pharmacies

Libby Baney, advisor for the Alliance for Safe Online Pharmacies, spoke as part of Panel 2, “Combating Drug Counterfeiting & Sales.” She moved the crowd in her opening statement with a personal story of her sister’s encounter with counterfeit drugs.

[...]